209 related articles for article (PubMed ID: 36389761)
1. Exploring the molecular mechanisms and shared gene signatures between rheumatoid arthritis and diffuse large B cell lymphoma.
Li H; Yu L; Zhang X; Shang J; Duan X
Front Immunol; 2022; 13():1036239. PubMed ID: 36389761
[TBL] [Abstract][Full Text] [Related]
2. Exploration of the molecular mechanisms, shared gene signatures, and MicroRNAs between systemic lupus erythematosus and diffuse large B cell lymphoma by bioinformatics analysis.
Peng Z; Liang X; Lin X; Lin W; Lin Z; Wei S
Lupus; 2022 Oct; 31(11):1317-1327. PubMed ID: 35817571
[TBL] [Abstract][Full Text] [Related]
3. Integrated bioinformatics analysis reveals dynamic candidate genes and signaling pathways involved in the progression and prognosis of diffuse large B-cell lymphoma.
Charwudzi A; Meng Y; Hu L; Ding C; Pu L; Li Q; Xu M; Zhai Z; Xiong S
PeerJ; 2021; 9():e12394. PubMed ID: 34760386
[TBL] [Abstract][Full Text] [Related]
4. Identification of the shared gene signatures and molecular pathways in systemic lupus erythematosus and diffuse large B-cell lymphoma.
Li H; Zhou J; Zhou L; Zhang X; Shang J; Feng X; Yu L; Fan J; Ren J; Zhang R; Duan X
J Gene Med; 2023 Dec; 25(12):e3558. PubMed ID: 37392050
[TBL] [Abstract][Full Text] [Related]
5. Expression of APRIL in diffuse large B cell lymphomas from patients with systemic lupus erythematosus and rheumatoid arthritis.
Löfström B; Backlin C; Pettersson T; Lundberg IE; Baecklund E
J Rheumatol; 2011 Sep; 38(9):1891-7. PubMed ID: 21724695
[TBL] [Abstract][Full Text] [Related]
6. Gene polymorphisms of LGALS2, LGALS3 and LGALS9 in patients with rheumatoid arthritis.
Xu WD; Wu Q; He YW; Huang AF; Lan YY; Fu L; Zhou J; Liu XY
Cell Immunol; 2021 Oct; 368():104419. PubMed ID: 34371260
[TBL] [Abstract][Full Text] [Related]
7. Identification of SLAMF1 as an immune-related key gene associated with rheumatoid arthritis and verified in mice collagen-induced arthritis model.
Li A; Zhang Z; Ru X; Yi Y; Li X; Qian J; Wang J; Yang X; Yao Y
Front Immunol; 2022; 13():961129. PubMed ID: 36110846
[TBL] [Abstract][Full Text] [Related]
8. Identification of PLA2G7 as a novel biomarker of diffuse large B cell lymphoma.
Zheng W; Lin Q; Issah MA; Liao Z; Shen J
BMC Cancer; 2021 Aug; 21(1):927. PubMed ID: 34404374
[TBL] [Abstract][Full Text] [Related]
9. Immune microenvironment-related gene mapping predicts immunochemotherapy response and prognosis in diffuse large B-cell lymphoma.
Chen W; Liang W; He Y; Liu C; Chen H; Lv P; Yao Y; Zhou H
Med Oncol; 2022 Jan; 39(4):44. PubMed ID: 35092504
[TBL] [Abstract][Full Text] [Related]
10. Analysis of endoplasmic reticulum stress-related gene signature for the prognosis and pattern in diffuse large B cell lymphoma.
Zhang C; Lin Q; Li C; Chen Z; Deng M; Weng H; Zhu X
Sci Rep; 2023 Aug; 13(1):13894. PubMed ID: 37626099
[TBL] [Abstract][Full Text] [Related]
11. Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma.
Zhou M; Zhao H; Xu W; Bao S; Cheng L; Sun J
Mol Cancer; 2017 Jan; 16(1):16. PubMed ID: 28103885
[TBL] [Abstract][Full Text] [Related]
12. Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature.
He J; Chen Z; Xue Q; Sun P; Wang Y; Zhu C; Shi W
J Transl Med; 2022 Apr; 20(1):186. PubMed ID: 35468826
[TBL] [Abstract][Full Text] [Related]
13. A novel lipid metabolism-based risk model associated with immunosuppressive mechanisms in diffuse large B-cell lymphoma.
Zhang Z; Zhao C; Yang S; Lu W; Shi J
Lipids Health Dis; 2024 Jan; 23(1):20. PubMed ID: 38254162
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of USP18 reduces tumor-infiltrating activated dendritic cells in extranodal diffuse large B cell lymphoma patients.
Zhao C; Huang R; Zeng Z; Yang S; Lu W; Liu J; Wei Y; Guo H; Zhang Y; Yan P; Huang Z; Shi J
Aging (Albany NY); 2021 May; 13(10):14131-14158. PubMed ID: 34001679
[TBL] [Abstract][Full Text] [Related]
15. Predictors of response of rituximab in rheumatoid arthritis by weighted gene co-expression network analysis.
Zhang S; Li P; Wu P; Yang L; Liu X; Liu J; Zhang Y; Zeng J
Clin Rheumatol; 2023 Feb; 42(2):529-538. PubMed ID: 36374432
[TBL] [Abstract][Full Text] [Related]
16. Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis.
Baecklund E; Natkunam Y; Backlin C; Iliadou A; Askling J; Ekbom A; Feltelius N; Klareskog L; Enblad G; Lossos IS; Levy R; Sundström C; Rosenquist R
Br J Haematol; 2008 Apr; 141(1):69-72. PubMed ID: 18324968
[TBL] [Abstract][Full Text] [Related]
17. Sirt6 promotes tumorigenesis and drug resistance of diffuse large B-cell lymphoma by mediating PI3K/Akt signaling.
Yang J; Li Y; Zhang Y; Fang X; Chen N; Zhou X; Wang X
J Exp Clin Cancer Res; 2020 Jul; 39(1):142. PubMed ID: 32711549
[TBL] [Abstract][Full Text] [Related]
18. CCL8 as a promising prognostic factor in diffuse large B-cell lymphoma
Lou X; Zhao K; Xu J; Shuai L; Niu H; Cao Z; Wang J; Zhang Y
Front Immunol; 2022; 13():950213. PubMed ID: 36072582
[TBL] [Abstract][Full Text] [Related]
19. Three hematologic/immune system-specific expressed genes are considered as the potential biomarkers for the diagnosis of early rheumatoid arthritis through bioinformatics analysis.
Cheng Q; Chen X; Wu H; Du Y
J Transl Med; 2021 Jan; 19(1):18. PubMed ID: 33407587
[TBL] [Abstract][Full Text] [Related]
20. Agent Repurposing for the Treatment of Advanced Stage Diffuse Large B-Cell Lymphoma Based on Gene Expression and Network Perturbation Analysis.
Xiang C; Ni H; Wang Z; Ji B; Wang B; Shi X; Wu W; Liu N; Gu Y; Ma D; Liu H
Front Genet; 2021; 12():756784. PubMed ID: 34721544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]